Loading…
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,548 other S bills in the 114th — cohort avg 43d
(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.) Highlights: This bill provides FY2017 appropriations for the Department of Agriculture (USDA), except for the Forest Service which is included in the Department of the Interior, Environment, and Related Agencies appropriations bill. It also provides appropriations for the Food and Drug Administration and the Farm Credit Administration. The bill includes both discretionary and mandatory funding. The mandatory funding levels are generally set by authorizing legislation such as the farm bill and are frequently limited in the agriculture appropriations bill. The bill decreases discretionary funding for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies below FY2016 levels. Also included in the bill are provisions that affect policies in areas such as: reporting requirements for Supplemental Nutrition Assistance Program (SNAP, formerly known as the food stamp program) households, inventory requirements for SNAP-authorized retailers, payments to farmers under the Agriculture Risk Coverage Program, labeling requirements for menus, labeling requirements for genetically engineered salmon, and horse slaughter facility inspections. Full Summary: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 Provides FY2017 appropriations to the Department of Agriculture (USDA), the Food and Drug Administration (FDA), and related agencies. TITLE I--AGRICULTURAL PROGRAMS Provides appropriations for the following agricultural programs and services: the Office of the Secretary; Executive Operations; the Office of the Chief Information Officer; the Office of the Chief Financial Officer; the Office of the Assistant Secretary for Civil Rights; the Office of Civil Rights; Agriculture Buildings and Facilities; Hazardous Materials Management; the Office of Inspector General; the Office of the General Counsel; the Office of Ethics; the Office of the Under Secretary for Research, Education, and Economics; the Economic Research Service; the National Agricultural Statistics Service; the Agricultural Research Service; the National Institute of Food and Agriculture; the Office of the Under Secretary for Marketing and Regulatory Programs; the Animal and Plant Health Inspection Service; the Agricultural Marketing Service; the Grain Inspection, Packers and Stockyards Administration; the Office of the Under Secretary for Food Safety; the Food Safety and Inspection Service; the Office of the Under Secretary for Farm and Foreign Agricultural Services; the Farm Service Agency; the Risk Management Agency; the Federal Crop Insurance Corporation Fund; and the Commodity Credit Corporation Fund. TITLE II--CONSERVATION PROGRAMS Provides appropriations for the Office of the Under Secretary for Natural Resources and Environment. Provides appropriations to the Natural Resources Conservation Service for: (1) Conservation Operations, and (2) Watershed and Flood Prevention Operations. TITLE III--RURAL DEVELOPMENT PROGRAMS Provides appropriations for Rural Development Programs including: the Office of the Under Secretary for Rural Development, Rural Development, the Rural Housing Service, the Rural Business--Cooperative Service, and the Rural Utilities Service. TITLE IV--DOMESTIC FOOD PROGRAMS Provides appropriations for the Office of the Under Secretary for Food, Nutrition, and Consumer Services. Provides appropriations to the Food and Nutrition Service for: Child Nutrition Programs; the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC); the Supplemental Nutrition Assistance Program (SNAP, formerly known as food stamps); the Commodity Assistance Program; and Nutrition Programs Administration. TITLE V--FOREIGN ASSISTANCE AND RELATED PROGRAMS Provides appropriations for the Foreign Agricultural Service, including: the Food for Peace Act (P.L. 480) and the McGovern-Dole International Food for Education and Child Nutrition Program. TITLE VI--RELATED AGENCIES AND FOOD AND DRUG ADMINISTRATION Provides appropriations to the Department of Health and Human Services for the Food and Drug Administration (FDA). Provides appropriations to the Farm Credit Administration. TITLE VII--GENERAL PROVISIONS Sets forth permissible and prohibited uses for funds provided by this and other appropriations Acts. (Sec. 701) Permits USDA to use funds provided by this bill for the purchase, replacement, and hire of passenger motor vehicles. (Sec. 702) Permits USDA to transfer unobligated balances to the Working Capital Fund for the acquisition of plant and capital equipment for financial, administrative, and information technology services. Permits the transferred funds to remain available until expended and specifies restrictions on the use of the funds. (Sec. 703) Prohibits appropriations provided by this bill from remaining available for obligation beyond the current fiscal year unless the bill expressly provides otherwise. (Sec. 704) Limits negotiated indirect costs on cooperative agreements between USDA and nonprofit institutions to 10% of the total direct cost of the agreement when the purpose of the agreement is to carry out programs of mutual interest between the two parties. (Sec. 705) Permits appropriations for direct and guaranteed loans to remain available until expended to disburse obligations made in the current fiscal year for: (1) the Rural Development Loan Fund program account, (2) the Rural Electrification and Telecommunication Loans program account, and (3) the Rural Housing Insurance Fund program account. (Sec. 706) Prohibits USDA from using funds provided by this bill to acquire or upgrade information technology systems without approval of the Chief Information Officer (CIO) and the Executive Information Technology Investment Review Board. Restricts the transfer of funds made available by this bill to the CIO without prior approval of Congress. Prohibits funds from being used for specified information technology projects without the approval of the CIO. (Sec. 707) Permits specified FY2017 funds provided under the Federal Crop Insurance Act for agricultural management assistance to remain available until expended to disburse obligations made in the current fiscal year. (Sec. 708) Makes a former Rural Utility Service borrower that has repaid or prepaid a loan under the Rural Electrification Act of 1936 or any not-for profit utility qualified to receive a loan under the Act eligible for rural economic development and job creation assistance in the same manner as a borrower. (Sec. 709) Permits up to $20 million of the unobligated balances from appropriations by this bill for salaries and expenses of the Farm Service Agency to remain available through FY2018 for information technology expenses. Permits unobligated balances from appropriations by this bill for salaries and expenses for the Rural Development mission area to remain available for information technology expenses through FY2018. (Sec. 710) Prohibits funds provided by this bill from being used for first-class travel by employees of agencies funded by this bill. (Sec. 711) Provides that Commodity Credit Corporation funds authorized or required to be used for specified programs included in the Agricultural Act of 2014: (1) shall be available for salaries and administrative expenses associated with the programs without regard to allotment and transfer limits, and (2) shall not be considered to be a fund transfer or allotment for purposes of applying the limits. (Sec. 712) Limits funds available for USDA advisory committees, panels, commissions, and task forces, except for panels used to comply with negotiated rulemaking or to evaluate competitively awarded grants. (Sec. 713) Prohibits funds provided by this bill from being used to pay indirect costs charged against any agricultural research, education, or extension grant awards issued by the National Institute of Food and Agriculture (NIFA) that exceed 30% of total federal funds provided under each award. Permits funds provided by this bill for grants awarded competitively by NIFA to be used to pay full allowable indirect costs for specified research and development grants awarded under the Small Business Act. (Sec. 714) Limits funds that may be used for the following programs: the Watershed Rehabilitation Program; the Environmental Quality Incentives Program; and the Biomass Crop Assistance Program; (Sec. 715) Limits funds for the following domestic food assistance categories: (1) Child Nutrition Programs Entitlement Commodities, (2) State Option Contracts, and (3) Removal of Defective Commodities. Limits FY2017 funds for the Fresh Fruit and Vegetable Program that provides fruit and vegetables to students in participating elementary schools. Prohibits USDA from using funds for payments authorized by Section 32 of the Agricultural Adjustment Act of 1935 to increase purchasing power of agricultural producers or for surplus removal or price support activities authorized by the Commodity Credit Corporation Charter Act. (Section 32 is a program created to assist agricultural producers of non-price-supported commodities and is funded by a permanent appropriation of a portion of the previous year's customs receipts less certain mandatory transfers to child nutrition and other programs. This provision effectively prohibits the use of Section 32 for emergency disaster payments.) Rescinds specified unobligated balances provided for domestic food assistance programs. (Sec. 716) Prohibits funds from being used to prepare proposals for the President's budget that assume savings from certain user fee proposals without identifying additional spending reductions that should occur if the proposals are not enacted. (Sec. 717) Sets forth procedures, requirements, and restrictions for reprogramming and transferring funds provided by this bill. (Sec. 718) Permits USDA to assess a one-time fee for any guaranteed business and industry loan in an amount that does not exceed 3% of the guaranteed principal portion of the loan. (Sec. 719) Prohibits funds from being used to provide questions or responses to questions requested for the appropriations hearing process to anyone not employed by an agency funded by this bill. (Sec. 720) Prohibits any executive branch agency from using funds provided by this bill to produce a prepackaged news story for U.S. broadcast or distribution unless it includes clear notification that it was produced or funded by the agency. (Sec. 721) Prohibits USDA employees from being detailed or assigned from an agency funded by this bill to any other USDA agency or office for more than 60 days in a fiscal year unless the individual's employing agency is reimbursed by the receiving agency for the salary and expenses of the employee. (Sec. 722) Prohibits funds provided by this bill from being used: (1) in contravention of a provision of the Agricultural Act of 2014 that permits an institution of higher education or a state department of agriculture to grow or cultivate industrial hemp for research purposes; or (2) to prohibit the transportation, processing, sale, or use of industrial hemp that is grown or cultivated in accordance with the Agricultural Act of 2014, within or outside the state in which it is grown or cultivated. (Sec. 723) Directs the agencies funded by this bill to submit spending plans to Congress. (Sec. 724) Appropriates funds for direct reimbursement payments for geographically disadvantaged farmers or ranchers to transport agricultural commodities. (Sec. 725) Requires USDA to establish an intermediary loan packaging program based on the FY2013 pilot program for packaging and reviewing section 502 single family direct loans. (The loan program assists low-income applicants in purchasing homes in rural areas. Funds may also be used to build, repair, or renovate a house, including providing water and sewage facilities.) (Sec. 726) Permits USDA to increase the program level by up to 25% for certain loans and loan guarantees that do not require budget authority and have program levels established by this bill. Requires congressional notification prior to implementing any increase. (Sec. 727) Provides that certain credit card refunds or rebates transferred to the Working Capital Fund: (1) shall not be available for obligation without congressional approval; and (2) shall only be available for the acquisition of plant and capital equipment for USDA financial, administrative, and information technology services. (Sec. 728) Directs USDA to set aside specified additional funds for Rural Economic Area Partnership (REAP) Zones. (Sec. 729) Permits USDA to respond to a community with inadequate drinking water supplies due to a natural disaster by providing potable water through the Emergency Community Water Assistance Grant Program for up to 120 days beyond the time period established in the program. (Sec. 730) Specifies the matching requirements that apply to funds appropriated for the Agriculture and Food Research Initiative. (Sec. 731) Provides additional funds for the Rural Energy Savings Program. (The program helps rural families and small businesses achieve cost savings by providing loans to consumers to implement durable cost-effective energy efficiency measures.) (Sec. 732) Appropriates funds for the pilot program to demonstrate new technologies that increase growth of re-forested hardwood trees on private nonindustrial forests lands on the coast of the Gulf of Mexico that were damaged by Hurricane Katrina in 2005. (Sec. 733) Sets forth the authorities that apply for USDA to provide loans for housing and buildings on adequate farms. (Sec. 734) Prohibits funds provided by this bill from being used for regulations to allow or require information intended for a prescribing health care professional, in the case of a drug or biological product, to be distributed electronically until a federal law is enacted to allow or require electronic distribution. (Sec. 735) Prohibits the FDA from using funds for the rule entitled "Food Labeling; Nutrition Labeling of Standard Menu Items in Restaurants and Similar Retail Food Establishments" until April 29, 2017. (Sec. 736) Prohibits the FDA from acknowledging applications for an exemption for investigational use of a drug or biological product in research in which a human embryo is intentionally created or modified to include a heritable genetic modification. Provides that any submission is deemed not to have been received, and the exemption may not go into effect. (Sec. 737) Prohibits funds from being used to implement or enforce any provisions of the FDA Food Safety Modernization Act, with respect to the regulation of the distribution, sale, or receipt of dried spent grain byproducts of the alcoholic beverage production process, irrespective of whether the byproducts are solely intended for use as animal feed. (Sec. 738) Provides appropriations to remain available until expended for implementing non-renewable agreements for wetlands preservation on eligible lands, including flooded agricultural lands. (Sec. 739) Permits USDA to receive access to certain information from federal tax returns to verify the income for individuals participating in loan programs under the Housing Act of 1949. (Sec. 740) Prohibits the FDA from deeming partially hydrogenated oils to be unsafe or any food containing a partially hydrogenated oil to be adulterated prior to June 18, 2018. (Sec. 741) Permits USDA to charge a fee for lenders to access USDA loan guarantee systems in connection with participation in the loan guarantee programs of the Rural Housing Service. (Sec. 742) Rescinds specified unobligated balances of funds provided to USDA for the Rural Housing and Community Development Service, the Rural Housing Service, Rural Business-Cooperative Service, and the Rural Utilities Service. (Sec. 743) Rescinds specified unobligated balances of funds provided to USDA for the Rural Housing and Community Development Service, the Rural Housing Service, the Rural Business-Cooperative Service, and the Rural Utilities Service. (Sec. 744) Requires a household that is certified to participate in SNAP to report when it no longer resides in the state in which it is certified. (Sec. 745) Rescinds specified unobligated balances from the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC). (Sec. 746) Provides additional funds to USDA for loans and grants that are consistent with the Healthy Food Financing Initiative and that support projects to provide access to healthy food in underserved areas, create and preserve quality jobs, and revitalize low-income communities. (Sec. 747) Rescinds specified unobligated balances of FY2015 funds that were provided to the Rural Development Salaries and Expenses account for the Comprehensive Loan Accounting System. Provides an equivalent amount of additional FY2016 funding to remain available through FY2017 for Information Technology modernization activities. (Sec. 748) Rescinds specified unobligated balances of FY2016 funds that were provided to the Rural Development Salaries and Expenses account for the Comprehensive Loan Accounting System. Provides an equivalent amount of additional funding to remain available through FY2018 for Information Technology modernization activities. (Sec. 749) Provides appropriations for a pilot program for USDA to award grants to non-profit organizations and public housing authorities to provide technical assistance to Rural Housing Service (RHS) multi-family housing borrowers to facilitate the acquisition of RHS multi-family housing properties in areas where there is a risk of loss of affordable housing. Requires the grants to be used to assist acquisitions by non-profit housing organizations and public housing authorities that commit to keep the properties in the RHS multi-family housing program for a period of time determined by USDA. (Sec. 750) Makes state agricultural experiment stations and state cooperative extension services eligible to enter into cooperative agreements with USDA to support the dissemination of objective, scholarly, and authoritative agricultural and food law research, legal tools, and information. (Sec. 751) Requires USDA to establish a pilot program to permit state Farm Service Agency offices to make county-level payments to agricultural producers under the Agriculture Risk Coverage Program using an alternate calculation method if it is necessary to ensure that there are not significant yield calculation disparities between comparable counties in the state. Specifies requirements for the alternative calculation method and provides appropriations for the program. (Sec. 752) Prohibits fund provided by this bill from being used for any portion of the rule entitled "Enhancing Retailer Standards in the Supplemental Nutrition Assistance Program (SNAP)" that would: alter the definition of a retail food store by establishing a threshold for the amount of food sales that must be for items that are not cooked or heated on-site; establish a minimum number of stocking units required for each food item in a staple food category; or alter the definition of staple food by: (1) changing the counting of commercially processed foods and prepared mixtures with multiple ingredients, or (2) expanding the scope of accessory food items. (Sec. 753) Specifies that, for the purposes of applying the Federal Food, Drug, and Cosmetic Act, the acceptable market name of Lithodes aequispinus is "golden king crab." (Sec. 754) Specifies that, for the purposes of applying the Federal Food, Drug, and Cosmetic Act , the acceptable market name of any salmon that is genetically engineered must include the words "genetically engineered" or "GE" prior to the existing acceptable market name. (Sec. 755) Prohibits funds from being used to inspect horses for slaughter purposes.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (134)
Placed on Senate Legislative Calendar under General Orders. Calendar No. 474.
Committee on Appropriations. Original measure reported to Senate by Senator Moran. With written report No. 114-259.
Introduced in Senate
Committee on Appropriations Senate Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies. Hearings held prior to introduction and/or referral. Hearings printed: S.Hrg. 114-696.
Committee on Appropriations Senate Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies. Hearings held prior to introduction and/or referral. Hearings printed: S.Hrg. 114-696.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2020 · second_quarter · Medical/Disease Research/Clinical Labs
Use of animals in biomedical research; moving medical research from bench to beside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tired with additional review in post-market; FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/S. 2956); importance of research using fetal tissue; FDA regulation of laboratory developed test; support for increased testing capacity to meet the demand posed by the COVID-19 pandemic; support for increase testing supplies to conduct coronavirus diagnostic tests; congressional support for FDA Emergency Use Authorization for OHSU 3D Printed CRISIS Ventilator; increased funding for federal research agencies in the Paycheck Protection Program and Health Care Enhancement Act, H.R. 266 and future pandemic relief legislation.
Client expense: $45,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Budget/Appropriations
FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/ S.2956); Inclusion of language to support research of PKAN, a rare inherited degenerative disorder, in a future appropriations bill.
Client expense: $45,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Medical/Disease Research/Clinical Labs
Use of animals in biomedical research; moving medical research from bench to beside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tired with additional review in post-market; FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/S. 2956); importance of research using fetal tissue; FDA regulation of laboratory developed test; support for increased testing capacity to meet the demand posed by the COVID-19 pandemic; support for increase testing supplies to conduct coronavirus diagnostic tests; congressional support for FDA Emergency Use Authorization for OHSU 3D Printed CRISIS Ventilator; increased funding for federal research agencies in the Paycheck Protection Program and Health Care Enhancement Act, H.R. 266.
Client expense: $45,000 · Firm income: Not reported
2020 · first_quarter · Budget/Appropriations
FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/ S.2956); Inclusion of language to support research of PKAN, a rare inherited degenerative disorder, in a future appropriations bill.
Client expense: $45,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Budget/Appropriations
FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/ S.2956); fiscal year 2020 Appropriations; H.R. 2740, Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; H.R. 3055, Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020; H.R. 3164, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020.
Client expense: $45,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Medical/Disease Research/Clinical Labs
Use of animals in biomedical research; moving medical research from bench to beside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tired with additional review in post-market; FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research Program; FDA regulation of laboratory developed test.
Client expense: $45,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Medical/Disease Research/Clinical Labs
Impact of Budget Control Act of 2011s Sequestration on medical records; use of animals in biomedical research; moving medical research from bench to beside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tired with additional review in post-market: 21st Century Cures Act (H.R> 34); FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research Program; FDA regulation of laboratory developed test.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Budget/Appropriations
FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/ S.2956); FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; H.R. 3358/S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2018; H.R. 1370, Further Additional Continuing Appropriations Act, 2018 (P.L. 115-96); H.R. 1892, Bipartisan Budget Act of 2018 (P.L. 115-123); H.R. 1625, Consolidated Appropriations Act, 2018 (P.L. 115-141); H.R. 6470/S/3158, departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019; H.R. 5961/S. 2976, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2019; H.R. 6157, Department of Defense and Labor, Health and Human Services, and education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (P.L. 115-245); Health and science related funding issues; H.J. Res. 31 Consolidated Appropriations Act of 2019; fiscal year 2020 Appropriations; H.R. 2740, Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; H.R. 3055, Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020; H.R. 3164, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Budget/Appropriations
FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/ S.2956); FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; H.R. 3358/S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2018; H.R. 1370, Further Additional Continuing Appropriations Act, 2018 (P.L. 115-96); H.R. 1892, Bipartisan Budget Act of 2018 (P.L. 115-123); H.R. 1625, Consolidated Appropriations Act, 2018 (P.L. 115-141); H.R. 6470/S/3158, departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019; H.R. 5961/S. 2976, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2019; H.R. 6157, Department of Defense and Labor, Health and Human Services, and education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (P.L. 115-245); Health and science related funding issues; H.J. Res. 31 Consolidated Appropriations Act of 2019; fiscal year 2020 Appropriations; H.R. 2740, Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; H.R. 3055, Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020; H.R. 3164, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Medical/Disease Research/Clinical Labs
Impact of Budget Control Act of 2011s Sequestration on medical records; use of animals in biomedical research; moving medical research from bench to beside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tired with additional review in post-market: 21st Century Cures Act (H.R> 34); FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research Program; FDA regulation of laboratory developed test.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · first_quarter · Medical/Disease Research/Clinical Labs
Impact of Budget Control Act of 2011s Sequestration on medical records; use of animals in biomedical research; moving medical research from bench to beside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tired with additional review in post-market: 21st Century Cures Act (H.R> 34); FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research Program; FDA regulation of laboratory developed test.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · first_quarter · Budget/Appropriations
FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/ S.2956); FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; H.R. 3358/S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2018; H.R. 1370, Further Additional Continuing Appropriations Act, 2018 (P.L. 115-96); H.R. 1892, Bipartisan Budget Act of 2018 (P.L. 115-123); H.R. 1625, Consolidated Appropriations Act, 2018 (P.L. 115-141); H.R. 6470/S/3158, departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019; H.R. 5961/S. 2976, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2019; H.R. 6157, Department of Defense and Labor, Health and Human Services, and education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (P.L. 115-245); Health and science related funding issues; H.J. Res. 31 Consolidated Appropriations Act of 2019; fiscal year 2020 Appropriations.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Budget/Appropriations
FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/ S.2956); FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; H.R. 3358/S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2018; H.R. 1370, Further Additional Continuing Appropriations Act, 2018 (P.L. 115-96); H.R. 1892, Bipartisan Budget Act of 2018 (P.L. 115-123); H.R. 1625, Consolidated Appropriations Act, 2018 (P.L. 115-141); H.R. 6470/ S. 3158, departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019; H.R. 5961/S. 2976, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2019; H.R. 6157, Department of Defense and Labor, Health and Human Services, and education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (P.L.115-245); Health and science related funding issues.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Medical/Disease Research/Clinical Labs
Impact of Budget Control Act of 2011s Sequestration on medical records; use of animals in biomedical research; moving medical research from bench to beside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tried with additional review in post-market: 21st Century Cures Act (H.R> 34); FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research Program; FDA regulation of laboratory developed test.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Medical/Disease Research/Clinical Labs
Impact of Budget Control Act of 2011s Sequestration on medical records; use of animals in biomedical research; moving medical research from bench to beside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tried with additional review in post-market: 21st Century Cures Act (H.R> 34); FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research Program; FDA regulation of laboratory developed test.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Budget/Appropriations
FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/ S.2956); FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; H.R. 3358/S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2018; H.R. 1370, Further Additional Continuing Appropriations Act, 2018 (P.L. 115-96); H.R. 1892, Bipartisan Budget Act of 2018 (P.L. 115-123); H.R. 1625, Consolidated Appropriations Act, 2018 (P.L. 115-141); H.R. 6470/ S. 3158, departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019; H.R. 5961/S. 2976, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2019; H.R. 6157, Department of Defense and Labor, Health and Human Services, and education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (P.L.115-245); Health and science related funding issues.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Budget/Appropriations
FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/ S.2956); FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; H.R. 244, Consolidated Appropriations Act 2017 (P.L. 115-31); H.R. 3358/S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2018; H.R. 1370, Further Additional Continuing Appropriations Act, 2018 (P.L. 115-96); H.R. 1892, Bipartisan Budget Act of 2018 (P.L. 115-123); H.R. 1625, Consolidated Appropriations Act, 2018 (P.L. 115-141); House Draft/ S. 3158, departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019;health and science related funding issue; H.R. 5961/S. 2976, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2019.
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Medical/Disease Research/Clinical Labs
Impact of Budget Control Act of 2011s Sequestration on medical records; use of animals in biomedical research; moving medical research from bench to beside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tried with additional review in post-market: 21st Century Cures Act (H.R> 34); FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research Program; FDA regulation of laboratory developed test.
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Budget/Appropriations
FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/ S.2956); FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; H.R. 244, Consolidated Appropriations Act 2017 (P.L. 115-31); H.R. 3358/S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2018; H.R. 1370, Further Additional Continuing Appropriations Act, 2018 (P.L. 115-96); H.R. 1892, Bipartisan Budget Act of 2018 (P.L. 115-123); H.R. 1625, Consolidated Appropriations Act, 2018 (P.L. 115-141); FY19 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; health and science related funding issues.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Medical/Disease Research/Clinical Labs
Impact of Budget Control Act of 2011s Sequestration on medical records; use of animals in biomedical research; moving medical research from bench to beside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tried with additional review in post-market: 21st Century Cures Act (H.R> 34); FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research Program; FDA regulation of laboratory developed test.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Budget/Appropriations
FDA Funding. H.R.5054/S.2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017. H.R.3354: Department of the Interior, Environment, and Related Agencies Appropriations Act, 2018.
Client expense: $1,290,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
2017 · fourth_quarter · Budget/Appropriations
FDA regulation of mitochondrial replacement therapy Sections 736 in "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017" (HR 5054/ S.2956); FY2017 funding for Zika: "Zika Response Appropriations Act, 2016" (HR5243), Division B in "Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017" (HR 2577). FY2017 and FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; HR 244, Consolidated Appropriations Act 2017 (P.L. 115-31); health and science related funding issues. HR 3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018; HJ Res. 123, Making further continuing appropriations for fiscal year 2018, and for other purposes (PL 115-90); HR 1370, Further Additional Continuing Appropriations Act, 2018 (PL 115-96); health and science related funding issues.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Medical/Disease Research/Clinical Labs
Impact of Budget Control Act of 2011's Sequestration on medical research; use of animals in biomedical research; moving medical research from bench to bedside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tied with additional review in post-market: "21st Century Cures Act" (H.R. 34); FDA regulation of mitochondrial replacement therapy Sections 736 in "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017" (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research program; FDA regulation of laboratory developed test.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Budget/Appropriations
FDA Funding. S.2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017. H.R.5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017. S.Con.Res.3: A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. H.R.3354: Department of the Interior, Environment, and Related Agencies Appropriations Act, 2018.
Client expense: $660,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
2017 · third_quarter · Medical/Disease Research/Clinical Labs
Impact of Budget Control Act of 2011's Sequestration on medical research; use of animals in biomedical research; moving medical research from bench to bedside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tied with additional review in post-market: "21st Century Cures Act" (H.R. 34); FDA regulation of mitochondrial replacement therapy Sections 736 in "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017" (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research program; FDA regulation of laboratory developed test.
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Budget/Appropriations
FY 2017 funding for NIH, Title VII and VIII of the Public Health Services Act, Center for Disease Control, Agency for HealthCare Research and Quality, Healthcare Resources and Services Administration, Office of Refugee Resettlement; Maternal Child Health Bureau further continuing and C.R. Security Assistance Appropriations Act, 2017 (H.R. 2028); FY2017 Funding for National Science Foundation; FY 2017 funding for USGS Columbia River program; FY 2017 funding for Department of Defense Health Research and for environmental exposures biomarkers research and lung injury research; FDA regulation of mitochondrial replacement therapy Sections 736 in "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017" (HR 5054/ S.2956); FY2017 funding for Zika: "Zika Response Appropriations Act, 2016" (HR5243), Division B in "Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017" (HR 2577). FY2017 and FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; HR 244, Consolidated Appropriations Act 2017 (P.L. 115-31); health and science related funding issues.
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · second_quarter · Health Issues
HR 244: Consolidated Appropriations Act, 2017; provisions related to Health and Human Services appropriations HR 1313: Preserving Employee Wellness Programs Act; provisions related to Genetic Information Nondiscrimination Act of 2008 and employee wellness programs HR 1628: American Health Care Act of 2017; all provisions H.R.5054 - (114th Congress) Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration appropriations S. 2956: (114th Congress) Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration appropriations S. 3040: (114th Congress) Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health, Heath Resources and Services Administration and Centers for Disease Control and Prevention appropriations Discussions related to Better Care Reconciliation Act; all provisions Discussions related to Fiscal Year 2018 Labor, Health and Human Services, and Education Appropriations; provisions related to funding for National Institutes of Health, Health and Human Services, Health Resources and Services Administration and Centers for Disease Control and Prevention and newborn screening funding Discussions related to Fiscal Year 2018 Agriculture Appropriations; provisions related to Food and Food and Drug Administration Discussions related to Health Care Reform
Client expense: $400,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · second_quarter · Budget/Appropriations
HR 244: Consolidated Appropriations Act, 2017; provisions related to funding for National Institutes of Health, Health and Human Services, Heath Resources and Services Administration and Centers for Disease Control, Prevention and Food and Drug Administration funding HR 5054: (114th Congress) Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding S. 2956: (114th Congress) Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding S. 3040: (114th Congress) Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health, Health and Human Services, Heath Resources and Services Administration and Centers for Disease Control, Prevention and newborn screening programs funding Discussions related to Fiscal Year 2017 Labor, Health and Human Services, Education, and related agencies appropriations bill; provisions related to National Institutes of Health, Health and Human Services, Health Resources and Services Administration and Centers for Disease Control and Prevention funding Discussions related to Fiscal Year 2018 Labor, Health and Human Services, and Education Appropriations; provisions related to funding for National Institutes of Health, Health and Human Services, Health Resources and Services Administration and Centers for Disease Control and Prevention, Food and Drug Administration, newborn screening funding Discussions related to Fiscal Year 2018 Agriculture Appropriations; provisions related to Food and Food and Drug Administration funding
Client expense: $400,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · second_quarter · Budget/Appropriations
FDA Funding. S.2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017. H.R.5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017. S.Con.Res.3: A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Client expense: $780,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)
2017 · first_quarter · Budget/Appropriations
FDA Funding. S.2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017. H.R.5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017. S.Con.Res.3: A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Client expense: $720,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2017 · second_quarter · Medical/Disease Research/Clinical Labs
Impact of Budget Control Act of 2011's Sequestration on medical research; use of animals in biomedical research; moving medical research from bench to bedside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tied with additional review in post-market: "21st Century Cures Act" (H.R. 34); FDA regulation of mitochondrial replacement therapy Sections 736 in "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017" (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research program; FDA regulation of laboratory developed test.
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · second_quarter · Budget/Appropriations
FY 2017 funding for NIH, Title VII and VIII of the Public Health Services Act, Center for Disease Control, Agency for HealthCare Research and Quality, Healthcare Resources and Services Administration, Office of Refugee Resettlement; Maternal Child Health Bureau further continuing and C.R. Security Assistance Appropriations Act, 2017 (H.R. 2028); FY2017 Funding for National Science Foundation; FY 2017 funding for USGS Columbia River program; FY 2017 funding for Department of Defense Health Research and for environmental exposures biomarkers research and lung injury research; FDA regulation of mitochondrial replacement therapy Sections 736 in "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017" (HR 5054/ S.2956); FY2017 funding for Zika: "Zika Response Appropriations Act, 2016" (HR5243), Division B in "Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017" (HR 2577). FY2017 and FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; HR 244, Consolidated Appropriations Act 2017 (P.L. 115-31); health and science related funding issues.
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · second_quarter · Budget/Appropriations
H.R.5054/S.2956, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017. H.R.662/S.441, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2015. Issues related to tobacco products.
Client expense: Not reported · Firm income: Not reported
2017 · second_quarter · Tobacco
H.R.5054/S.2956, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017. H.R.662/S.441, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2015. Issues related to tobacco products.
Client expense: Not reported · Firm income: Not reported
2017 · first_quarter · Budget/Appropriations
FY 2017 funding for NIH, Title VII and VIII of the Public Health Services Act, Center for Disease Control, Agency for HealthCare Research and Quality, Healthcare Resources and Services Administration, Office of Refugee Resettlement; Maternal Child Health Bureau further continuing and C.R. Security Assistance Appropriations Act, 2017 (H.R. 2028); FY2017 Funding for National Science Foundation; FY 2017 funding for USGS Columbia River program; FY 2017 funding for Department of Defense Health Research and for environmental exposures biomarkers research and lung injury research; FDA regulation of mitochondrial replacement therapy Sections 736 in "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017" (HR 5054/ S.2956); FY2017 funding for Zika: "Zika Response Appropriations Act, 2016" (HR5243), Division B in "Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017" (HR 2577). FY2017 and FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; health and science related funding issues.
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · first_quarter · Medical/Disease Research/Clinical Labs
Impact of Budget Control Act of 2011's Sequestration on medical research; use of animals in biomedical research; moving medical research from bench to bedside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tied with additional review in post-market: "21st Century Cures Act" (H.R. 34); FDA regulation of mitochondrial replacement therapy Sections 736 in "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017" (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research program; FDA regulation of laboratory developed test.
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · first_quarter · Agriculture
H.R. 5054 (114th Congress) /S.2956 (114th Congress): FY2017 Appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Titles I and VI--all provisions related to research, extension, education and food safety. (FY '17 funding was not completed prior to the conclusion of the 114th Congress and is operating under a continuing resolution through April 28th, 2017) H.R. TBD/S.TBD: FY2018 Appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Titles I and VI--all provisions related to research, extension, education and food safety. H.R. 5912/S. 3117: FY2017 Appropriations for foreign operations, export financing, and related programs, title II -- provisions related to international agricultural research and food security. (FY '17 operating under CR through April 28th, 2017) H.R. TBD/S.TBD : FY2018 Appropriations for foreign operations, export financing, and related programs, title II -- provisions related to international agricultural research and food security.
Client expense: $90,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · first_quarter · Budget/Appropriations
FDA Funding. S.2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017. H.R.5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017. S.Con.Res.3: A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Client expense: $720,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2017 · first_quarter · Budget/Appropriations
The association follows the federal budget and appropriations process as it relates to agencies, and their respective policies, that have jurisdiction over rural telecommunications matters. Primarily the association monitors the Federal Communications Commission(FCC), the National Telecommunications and Information Administration(NTIA), and the Rural Utilities Service(RUS), and the budget, programs, and policies of each. During the reporting period, the association focused on the following: Fiscal Year 2018 appropriations discussions regarding the perspective of rural broadband providers as they relate to: - U.S. Dept. of Agriculture Rural Utilities Service Telecommunications Loan and Grant program funding; applicant review and approval sequencing; and applicant compliance with related National Environmental Protection Act and National Historic Preservation Act requirements - U.S. Dept. of Agriculture Rural Business Cooperative Service Rural Economic Development Loan and Grant Program - U.S. Dept. of Agriculture Forest Service budgets and policies for permitting access to federal lands and property - Federal Communications Commission oversight of Universal Service Fund and related policies as well as policies tied to other aspects of rural communications operations - Federal Election Commission regulations dealing with solicitation prior approvals S.2956 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 - Title III (Rural Development Programs). S.3067 - Financial Services and General Government Appropriations Act, 2017 - Sections 501, 502, 633. H.R.5054 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 - Title III (Rural Development Programs). H.R.5485 - Financial Services and General Government Appropriations Act, 2017 - Sections 631, 636, and section dealing with trade association prior approvals under FEC rules.
Client expense: $230,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), SENATE, White House Office
2017 · first_quarter · Medical/Disease Research/Clinical Labs
Impact of Budget Control Act of 2011's Sequestration on medical research; use of animals in biomedical research; moving medical research from bench to bedside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tied with additional review in post-market: "21st Century Cures Act" (H.R. 34); FDA regulation of mitochondrial replacement therapy Sections 736 in "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017" (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research program; FDA regulation of laboratory developed test.
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · first_quarter · Budget/Appropriations
FY 2017 funding for NIH, Title VII and VIII of the Public Health Services Act, Center for Disease Control, Agency for HealthCare Research and Quality, Healthcare Resources and Services Administration, Office of Refugee Resettlement; Maternal Child Health Bureau further continuing and C.R. Security Assistance Appropriations Act, 2017 (H.R. 2028); FY2017 Funding for National Science Foundation; FY 2017 funding for USGS Columbia River program; FY 2017 funding for Department of Defense Health Research and for environmental exposures biomarkers research and lung injury research; FDA regulation of mitochondrial replacement therapy Sections 736 in "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017" (HR 5054/ S.2956); FY2017 funding for Zika: "Zika Response Appropriations Act, 2016" (HR5243), Division B in "Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017" (HR 2577). FY2017 and FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; health and science related funding issues.
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · first_quarter · Budget/Appropriations
H.R. 5054 / S. 2956 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (114th Cong.); H.R. 5293 / S. 3000 - Department of Defense Appropriations Act, 2017 (114th Cong.); H.R.1301 - Department of Defense Appropriations Act, 2017 (115th Cong.); H.R. 5634 / S. 3001 - Department of Homeland Security Appropriations Act, 2017 (114th Cong.); H.R. 5538 / S.3068 - Interior, Environment, and Related Agencies Appropriations Act, 2017 (114th Cong.); H.R. 5912 / S. 3117 - State, Foreign Operations, and Related Programs Appropriations Act, 2017 (114th Cong.); H.R.2028 - Further Continuing and Security Assistance Appropriations Act (114th Cong.): Appropriations issues related to the provision of emergency vehicles.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · first_quarter · Budget/Appropriations
S 2956/H.R. 5054 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 FY 2018 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act
Client expense: $220,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE
2017 · first_quarter · Budget/Appropriations
H.R. 5054/S. 2956, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 -Funding for agricultural research and education H.R. 2578/S. 2837, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2016 -Funding for NSF, NIST and NASA H.R. 5293/S. 3000, Department of Defense Appropriations Act, 2017 -Funding for 6.1, 6.2 and 6.3 research and development programs within DOD H.R. 5055/S. 2028, Energy and Water Development and Related Agencies Appropriations Act, 2017 -Funding for the DOE Office of Science and ARPA-E H.R. 5634/S. 3001, Department of Homeland Security Appropriations Act, 2017 -Funding for DHS S&T programs H.R. 5926/S. 3040, An original bill making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2017, and for other purposes. -Funding for NIH, Pell Grants and other higher education programs through the Department of Education H.R. 5394/H.R. 2577/S. 2844, An original bill making appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies for the fiscal year ending September 30, 2017, and for other purposes. -Funding for transportation research and development
Client expense: $15,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Health Issues
PL 112-144, The Food & Drug Administration Safety and Innovation Act, sections 1111 to 1113 (Medical Gas Provisions) H.R.5054 & S.2956 Agriculture, Rural Development, FDA & Related Agencies Appropriations Act for FY17, FDA provisions
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Health Issues
PL 112-144, The Food & Drug Administration Safety and Innovation Act, sections 1111 to 1113 (Medical Gas Provisions) H.R.5054 & S.2956 Agriculture, Rural Development, FDA & Related Agencies Appropriations Act for FY17, FDA provisions
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Health Issues
PL 112-144, The Food & Drug Administration Safety and Innovation Act, sections 1111 to 1113 (Medical Gas Provisions) H.R.5054 & S.2956 Agriculture, Rural Development, FDA & Related Agencies Appropriations Act for FY17, FDA provisions
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Education
S. 2956; HR 5926 - HHS FY 17 Appropriations priorities: AHRQ, HRSA, Title VII, NHSC, Title X, CARA: AAFP federal spending priorities for primary care training research and access. Cures (HR 6) and Mental Health Reform Bill (HR 2646); Support for health IT interoperability, mental health integration and mental health parity. Interest in Medicaid. No Bill No.-Graduate Medical Education: Advocate for introduction of a bill to fix problem caused by "rotators" who establish low caps and PRAs; Express AAFP's overall GME reform policies to Congress; Advocate for solution to VACAA Expansion slots - how to fill them with more family medicine residents; Advocate for the introduction of a bill to help resolve problems specific to the rural GME; Advocate for introduction of a Resolution to support stability in the Teaching Health Center GME program; Explain and advocate for AAFP's policy proposals on GME; Support for teaching Health Center Reauthorization. No Bill No. - FY2018 appropriations for HRSA Title VII 747: Primary Care Training and Enhancement Grants. No Bill No - Advisory Committee on Training in Primary Care Medicine and Dentistry. No Bill No. - Transforming Primary Care for 21st Century THC, GME and NHSC. No Bill N0. - Teaching Health Center Graduate Medical Education permanence: Increasing primary care workforce; maintain the sustainability of the THCGME program. No Bill No. - National Advisory Council on the National Health Service Corps: Medical student debt relief, improved access to primary care. No Bill No. - Coalition for Health Funding - AAFP Health is Primary booth: Raising awareness of AAFP and value of primary care; increasing primary care workforce. No Bill No - FY 2016 appropriations AHRQ, HRSA Title VII, NHSC: AAFP Federal spending priorities to support workforce, research. No Bill No. - Congressional Primary Care Caucus - Urge members to join the Caucus and support Primary Care to achieve the triple aim in health care.
Client expense: $749,400 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
2016 · third_quarter · Budget/Appropriations
S. 2956; HR 5926 - HHS FY 17 Appropriations priorities: AHRQ, HRSA, Title VII, NHSC, Title X, CARA: AAFP federal spending priorities for primary care training research and access. HR 2577, HR 5243 HR 4973 - Funding for Zika emergency response: Public Health. HR 5325 Continuing Appropriations and Military Construction, Veterans Affairs, Appropriation Act, 2017 and Zika Response and Preparedness Act: Zika public health response funding in FY 2016 & FY 2017. No Bill No. - Coalition for Health Funding - AAFP Health is Primary booth: Raising awareness of AAFP and value of primary care. No Bill No. - FY2018 appropriations for HRSA Title VII 747: Primary Care Training and Enhancement Grants. No Bill No - Advisory Committee on Training in Primary Care Medicine and Dentistry. No Bill No - FY 2016 appropriations AHRQ, HRSA Title VII, NHSC: AAFP Federal spending priorities to support workforce, research.
Client expense: $749,400 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
2016 · third_quarter · Budget/Appropriations
Accelerating Biomedical Research Act(S.318/ H.R.531) American Cures Act (S.289/ H.R.2104) FY2016 Agriculture Appropriations (S.1800/ H.R.3049) FY2017 Agriculture Appropriations (H.R.5054/S.2956) FY2017 Labor-HHS-Education Appropriations-provisions relating to CDC,HRSA,AHRQ, NIH,and Education(S.3040/H.R.5926) FY2017 Milcon-VA Appropriations-telestroke(S.2806/H.R.2577) FY2017 Transportation/HUD Approps (air ambulance amendment) House Energy and Commerce Committee Budget Reconciliation Instructions House/Senate Health Care Budget Reconciliation (H.R.3762) National Biomedical Research Act (S.2624) National Defense Authorization Act for FY 2017(S.2943) Research for All Act(H.R.2101) Senate Innovations Bill
Client expense: $166,728 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office